A Novel Mutation Causing Complete Thyroid Binding Globulin Deficiency (Tbg-Cd Mia) In A Male With Coexisting Graves Disease

Abstract

Objective An asymptomatic male was found on screening to have a low serum TSH and total T4. The diagnosis of Graves’ disease was made with positive thyroid stimulating immunoglobulin (TSI) and elevated free T4 in the presence of complete TBG deficiency (TBG-CD). Genetic testing of the patient and family members revealed a novel frameshift mutation in the TBG (SERPINA7) gene resulting in a complete deficiency of the protein. Methods The laboratory testing included total T4, free T4 by analog method and direct dialysis and TBG measurements. Sequencing of genomic DNA was performed from peripheral blood. Results A 35-year-old East Indian male was referred to endocrinology because of abnormal thyroid function tests (TFTs): TSH 0.01 mIU/L (0.4–3.6), total T4 3.0 µg/dl (5.5–10.5) done as part of a “routine office visit”. Upon further testing, the serum free T4 2.0 ng/dl (0.8–1.8) and TSI 355% (<140% baseline) were elevated and the diagnosis of Graves’ disease was made. TBG deficiency was suspected because the total T4 concentration was inconsistent with hyperthyroidism and further testing confirmed TBG was undetectable. Sequencing of the TBG gene revealed a novel hemizygous frameshift mutation: p.Ala64ProfsTer106, TBG-CD Mia (numbering excludes 20 a.a. signal peptide) associated with the complete deficiency of TBG in a patient with Graves’ disease. Conclusion Patients with Graves’ disease harboring a TBG mutation have conflicting TFTs. If a clinically hyperthyroid patient presents with normal or low total T4, serum TBG should be measured to identify an abnormality and prevent unnecessary testing.

Transcriptome analysis of sinensetin-treated liver cancer cells guided by biological network analysis

“…One study on 30 patients with primary liver cancer has found that 22 of them have higher TBG concentrations. Additionally, in 28 out of 31 patients with liver metastasis, TBG concentration is higher than normal ( 39 ).…”

The impact of thyroid hormone dysfunction on ischemic heart disease

“…Furthermore, THs are mainly active when not bound to transport proteins. Therefore, variations on binding protein levels can change the peripheral activity of THs (5). In order to perform their roles, THs must bind to thyroid hormone receptors.…”

Clinical recognition and evaluation of patients with inherited serum thyroid hormone-binding protein mutations

“…Notably, a number of cases of TBG deficiency have been reported in patients with concurrent Graves' disease. These patients exhibit a confounding pattern of TFTs with an undetectable or low TSH and low or low-normal TT4 and TT3, but elevated free thyroid hormones [26,27], reviewed in [27]. In these patients, obtaining a serum TBG level and careful assessment of clinical status can be useful in avoiding inappropriate therapy.…”